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translated, but where the entire primary sequence of the
protein is not the information that is under selection. In
many cases, the number of amino acids under selection
could be few or none, which can lead to the appearance of a
high Ka/Ks ratio, even though there is selection for
expression of the small protein sequence. For example,
leader peptides are small proteins that have critical roles
in gene expression through translational control [2]. Here,
pausing of the ribosome during translation of a leader
protein may allow for the formation of an anti-terminator
RNA structure, thereby allowing transcription of the
downstream genes in an operon. If the ribosome does not
pause, a rho-independent terminator will form and the
operon is not expressed. Leader peptides in the Escher-
ichia coli genome control the thr, leu, trp and phe operons,
and their Ka/Ks ratios are far greater than expected for
protein-coding genes (three of them are even greater than
Ochman’s conservative m þ 2s threshold, Fig. 1a), which
would seem to indicate that these small ORFs do not
encode proteins. In reality, only amino acids responsible
for ribosome pausing when a charged tRNA becomes
depleted (e.g. two tryptophan codons in the trpL gene)
might be under selection for amino acid identity. The
additional residues of the leader peptide are not under
selection for the function of the protein (although they can
participate in mRNA secondary structure formation).
Similar leader peptides are found upstream of the tnaA
tryptophanase gene [3,4] and chloramphenicol resistance
genes [5] and operate by different methods. Similar small
upstream ORFs occur in eukaryotic genomes (e.g. the 25-
codon arginine-sensing peptide cotranscribed with the
Saccharomyces cerevisiae CPA1 gene [6]). But the end result
is the same: the short length, poor conservation and often
unusual composition of these leader peptides can easily lead
one to dismiss the coding potential of their genes.
In some cases, the majority of a peptide could be dis-
posable, also leading to high Ka/Ks ratios. Although small
disposable portions are commonly seen among leader
sequences for secreted proteins, or pro-proteins made in
inactive states (e.g. Bacillus pro-s factors); the most
extreme case might be the pqqA peptide, which is over-
produced relative to other proteins in the Klebsiella pqq
operon and may serve as the substrate for the synthesis of
the cofactor PQQ [7,8]. Here, the amino acids glutamate
and tyrosine may be cleaved from the peptide backbone
and serve as the substrate for cofactor biosynthesis, and
the remaining residues may serve as a scaffold. Some
transcribed regions may not encode polypeptides at all.
The Ka/Ks test is useless in the identification of small
functional RNAs, which can have important roles in
cellular metabolism, and may be great in number [9].
Some of the regions designated as small ORFs – even
those with genetic evidence for their importance – may act
through an RNA product.
The manifold ways small protein products affect
cellular metabolism make their identification onerous,
and sometimes even comparisons with closely related
genomes cannot aid in their unambiguous identification.
In these cases, hands-on experimentation could be the
only route towards gene discovery and the potentially
fascinating insights in molecular biology that can result.
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Recently, a novel cGMP signalling cascade was uncovered
in Dictyostelium, a eukaryote that diverged from the line-
age leading to metazoa after plants and before yeast. In
both Dictyostelium and metazoa, the ancient cAMP-bind-
ing (cNB) motif of bacterial CAP has been modified and
assembled with other domains into cGMP-target pro-
teins. The domain structures of these cGMP targets, as
well as the enzymes responsible for cGMP synthesis and
degradation, are entirely different between Dictyostelium
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and metazoa, suggesting that different cGMP-signalling
pathways evolved in these two lineages.
In metazoa, cGMP is synthesized by two guanylyl
cyclases, one membrane-bound and the other soluble,
that have a common phylogenetic predecessor (Fig. 1).
Close homologues of these proteins are not found in
Dictyostelium. Instead, the two Dictyostelium guanylyl
cyclases, GCA and sGC, resemble adenylyl cyclases: GCA
has the topology of the ubiquitous twelve membrane-
spanning metazoan adenylyl cyclases, whereas sGC is
homologous to a small family of soluble adenylyl cyclases
present in vertebrates and bacteria [1,2].
Cyclic GMP is degraded in metazoa by class I phospho-
diesterases, several of which are activated by cGMP-binding
to GAF domains [3]. Dictyostelium also expresses
cGMP-activated phosphodiesterases (PDE5 and PDE6;
original names GbpA and GbpB, respectively), but
these enzymes have a common evolutionary origin that
is entirely different from the origin of metazoan
enzymes [4–6]. Instead of a class I phosphodiesterase
they contain the unrelated class II phosphodiesterase
found only in bacteria and primitive eukaryotes, and
cGMP stimulation is mediated by cNB domains instead
of GAF domains, two structurally and evolutionarily
unrelated cyclic nucleotide binding domains.
In metazoa, cGMP signalling is mediated by
cGMP-regulated protein kinase (PKG), ion channels and
possibly Ras guanine nucleotide exchange factors
(CNRasGEF), all of which possess cNB domains [7,8].
cGMP signalling in Dictyostelium is mediated by GbpC
and D [4,5]. Although the combination of cNB and RasGEF
domains in GbpC and D is reminiscent of CNRasGEF, the
domains are shuffled, and in phylogenetic analysis the
cNB domains from CNRasGEF group with those in protein
kinases, whereas the cNB domains of GbpC and D are
more closely related to bacterial CAP. The protein kinase
domain of GbpC is homologous to mitogen-activated protein
Fig. 1. cGMP signalling in Dictyostelium and metazoa. Domains are colour-coded by biochemical functions, and have the same shape if they are evolutionarily closely
related. cGMP is produced by cyclases (blue, with a black dot for the catalytic site) and degraded by phosphodiesterases (PDE, orange). The domains that bind cGMP are
red, and the domains that mediate the downstream effects of cGMP are shades of green; N refers to the N-terminus of the proteins. The order of domains in Dictyostelium
is generally the opposite of that in metazoa. PDE5 and PDE6 are phosphodiesterases with identical domain composition, that are encoded by the gbpA and gbpB genes,
respectively. GbpD is homologous to the C-terminal part of GbpC, including the GEF and cNB domains.
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Fig. 2. Species tree. The phylogeny of species derived from the estimated diver-
sion time of several proteins in human, Drosophila, yeast, plants, Plasmodium and
bacteria [11]. The phylogenetic position of Dictyostelium has been determined in
two independent studies [12,13]. Dictyostelium is a member of a group of early
eukaryotes including Entamoebae and Mastigamoeba, called Canosa [13,14]. The
presence of cGMP signalling the other Canosa species is unknown. cGMP signal-
ling is absent in yeast, plants and most bacteria, but is present in Plasmodium and
the related species Paramecium and Tetrahymena. The scale indicates the esti-
mated species divergence time before present. Myr, million years.
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kinase kinase kinase (MAPKKK), placing it in an entirely
different branch of the protein kinase superfamily from
PKG. TheRas and MAPKKK regionofGbpC is similar to the
human protein KIAA1790, suggesting that GbpC might
have arisen by fusion of a KIAA1790-like protein with a
protein containing RasGEF and cNB domains.
Cyclic GMP signalling does not appear to occur in
eubacteria, yeast and plants, whereas Drosophila and
Caenorhabditis elegans have cGMP signalling proteins
that are similar to those found in vertebrates. There is also
evidence for guanylyl cyclases in cyanobacteria [9],
Paramecium, Tetrahymena and Plasmodium [10]. As the
last common ancestor of Dictyostelium and metazoa
evolved after Plasmodium (Fig. 2), it will be interesting
to see how other cGMP signalling proteins deduced from
the completed genome of Plasmodium compare with the
systems in Dictyostelium and metazoa.
At this juncture it is clear that phylogenetically distinct
cGMP signalling components have evolved in the ancestor
of Dictyostelium and in the ancestor of metazoa, to create
two different but in many ways analogous cGMP signalling
pathways.
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